GlassScriptPhysician profile
Kimberly D Matthews
NPI 1003843327
$2,573.60
in general payments reported to CMS, 2019-2025
27 companies · $524 in 2025
The $524 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $418 · 2020: $74.92 · 2021: $61.84 · 2022: $382 · 2023: $544 · 2024: $569 · 2025: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,636.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $402.77 | 2019-2023 | |
| Biogen, INC. | $387.61 | 2024-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $301.32 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $195.52 | 2023-2024 | Myfembree |
| Astellas Pharma US INC | $190.48 | 2019-2025 | Veozah |
| Pfizer INC. | $141.12 | 2019-2023 | |
| Daiichi Sankyo INC. | $112.84 | 2019-2023 | Injectafer |
| Organon LLC | $107.02 | 2022-2025 | Nexplanon |
| Exeltis, USA INC. | $101.18 | 2019-2024 | Slynd |
| Coopersurgical, INC. | $81.24 | 2020-2024 | Paragard T 380a, Paragard T 380a |
| Shield Therapeutics INC | $73.24 | 2025 | |
| Hologic Sales and Service, LLC | $59.92 | 2022-2024 | Aptima, Thinprep 2000 Processor |
| Bayer Healthcare Pharmaceuticals INC. | $59.40 | 2019-2025 | |
| Millicent US INC | $52.71 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Baxter Healthcare | $47.77 | 2020-2024 | Perclot |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $41.09 | 2019-2022 | |
| Myovant Sciences INC. | $31.32 | 2021-2022 | |
| Allergan, INC. | $29.16 | 2019-2020 | |
| Evofem Biosciences, INC. | $26.77 | 2022 | |
| Endo Pharmaceuticals INC. | $23.74 | 2019 | |
| Applied Medical Resources Corporation | $17.80 | 2023 | |
| Sage Therapeutics, LLC | $17.73 | 2019 | |
| Medtronic, INC. | $16.71 | 2024 | Truclear |
| Ethicon US, LLC | $16.61 | 2019 | |
| Amag Pharmaceuticals, INC. | $14.47 | 2019 | |
| Scynexis, INC. | $12.52 | 2022 | |
| Duchesnay USA Incorporated | $11.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Matthews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.